2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Immunization, Passive: new trials by email Literature Review of Immunization, Passive trials Research Report on Immunization, Passive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease Immunotoxin therapy, CAT-8015 Immunotoxin, Biological therapy - Leukemia, Non-Hodgkin's Lymphoma | Phase 1 | Unknown | Cambridge Antibody Technology | 50 | 2007-08-01 | 2007-08-14 |
| Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer antibody therapy, biological therapy, muromonab-CD3 - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Unknown | St. Vincent Medical Center - Los Angeles | 1991-06-01 | 2013-11-06 |
Leukemia (1) · Lymphoma, Non-Hodgkin (1)
Cambridge Antibody Technology (1) · St. Vincent Medical Center - Los Angeles (1)
United States (2) · Poland (1)